Trial
NCT01460654
Testosterone and Alendronate in Hypogonadal Men
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
Endo USA Inc., a Keenova Therapeutics Company; Merck Sharp & Dohme LLC
Condition
Hypogonadism
Intervention
Testosterone
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-12